alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                          36,434
<SECURITIES>                                         0
<RECEIVABLES>                                   35,889
<ALLOWANCES>                                     3,248
<INVENTORY>                                          0<F1>
<CURRENT-ASSETS>                                     0<F2>
<PP&E>                                           2,490
<DEPRECIATION>                                   1,281
<TOTAL-ASSETS>                                 185,115
<CURRENT-LIABILITIES>                                0<F2>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        70,379
<OTHER-SE>                                     (9,634)
<TOTAL-LIABILITY-AND-EQUITY>                   185,115
<SALES>                                            711
<TOTAL-REVENUES>                                49,890
<CGS>                                              723
<TOTAL-COSTS>                                   39,666
<OTHER-EXPENSES>                                31,186
<LOSS-PROVISION>                                 2,959
<INTEREST-EXPENSE>                               7,782
<INCOME-PRETAX>                                  5,197
<INCOME-TAX>                                       726
<INCOME-CONTINUING>                              4,471
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,471
<EPS-BASIC>                                        .38
<EPS-DILUTED>                                      .36
<FN>
<F1>Included in total assets is $91,499 representing net film and television
program assets.
<F2>The Company presents its financial position in an unclassified consolidated
balance sheet.
</FN>


</TABLE>
Case 2:03-cv-05336-LDD Document 853 Filed 01/08/13 Page 1 of 1
No. 58413.

protests 983581-G and 172485-K (New York).

#### S. S. Kresge Company and F. W. Woolworth Company *v.*United States,

Opinion by

Oliver, C. J.

In accordance with stipulation of counsel that the merchandise consists of papier-máché articles the same in all material respects as those the subject of Abstract 56975, the items marked “A” were held dutiable at 12)4 percent under paragraph 1403, as modified, *su-pra,*and the items marked “D” at 25 percent under paragraph 1403 of the tariff act.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### National Science Foundation

In accordance with the Federal Advisory Committee Act (Pub. L. 92-463, as amended), the National Science Foundation (NSF) announces its intent to hold proposal review meetings throughout the year. The purpose of these meetings is to provide advice and recommendations concerning proposals submitted to the NSF for financial support. The agenda for each of these meetings is to review and evaluate proposals as part of the selection process for awards. The review and evaluation may also include assessment of the progress of awarded proposals. These meetings will primarily take place at NSF's headquarters, 2415 Eisenhower Avenue, Alexandria, VA 22314.

These meetings will be closed to the public. The proposals being reviewed include information of a proprietary or confidential nature, including technical information; financial data, such as salaries; and personal information concerning individuals associated with the proposals. These matters are exempt under 5 U.S.C. 552b(c), (4) and (6) of the Government in the Sunshine Act. NSF will continue to review the agenda and merits of each meeting for overall compliance of the Federal Advisory Committee Act.

                    These closed proposal review meetings will not be announced on an individual basis in the                     **Federal Register**                    . NSF intends to publish a notice similar to this on a quarterly basis. For an advance listing of the closed proposal review meetings that include the names of the proposal review panel and the time, date, place, and any information on changes, corrections, or cancellations, please visit the NSF website:                     *https://new.nsf.gov/​events/​proposal-review-panels.*                     This information may also be requested by telephoning, 703/292-8687.                

Dated: November 2, 2023.

Crystal Robinson,

Committee Management Officer.

[FR Doc. 2023-24542 Filed 11-6-23; 8:45 am]

BILLING CODE 7555-01-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Commodity Futures Trading Commission

# TIME AND DATE: 

9:30 a.m. EDT, Wednesday, November 1, 2023.

# PLACE: 

CFTC Headquarters Conference Center, Three Lafayette Centre, 1155 21st Street NW, Washington, DC.

# STATUS: 

Open.

# MATTERS TO BE CONSIDERED: 

The Commodity Futures Trading Commission (Commission or CFTC) will hold this meeting to consider the following matter:
      -  Proposed Rule:                          Investment of Customer Funds by Futures Commission Merchants and Derivatives Clearing Organizations.                    

                        The agenda for this meeting will be available to the public and posted on the Commission's website at                         *https://www.cftc.gov.*                         Members of the public are free to attend the meeting in person, or have the option to listen by phone or view a live stream. Instructions for listening to the meeting by phone and connecting to the live video stream will be posted on the Commission's website.                    

In the event that the time, date, or place of this meeting changes, an announcement of the change, along with the new time, date, or place of the meeting, will be posted on the Commission's website.

# CONTACT PERSON FOR MORE INFORMATION: 

Christopher Kirkpatrick, Secretary of the Commission, 202-418-5964.

*Authority:*5 U.S.C. 552b.                    

Dated: October 25, 2023.

Christopher Kirkpatrick,

Secretary of the Commission.

[FR Doc. 2023-23951 Filed 10-26-23; 11:15 am]

BILLING CODE 6351-01-P
# DATA Act Quarterly Reporting

# DATA Act Monthly Reporting

# GTAS Reporting Window

# Program Activity Schedule
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

BONNIE CLIPSON :

: CIVIL ACTION NO. 02-CV-4137

Plaintiff, :

:

v. :

:

BAYER CORPORATION;

BAYER AG;

GLAXOSMITHKLINE, PLC;

GLAXOSMITHKLINE;

SMITHKLINE BEECHAM

:

:

:

:

:

ENTRY OF APPEARANCE

:

Defendants. :

ENTRY OF APPEARANCE

To the Clerk of the Court:

Kindly enter the appearances of Hope S. Freiwald, Aline Fairweather, Erin

Brennan and Kirstin J. Miller as attorneys for defendant GlaxoSmithKline PLC.

Respectfully Submitted,

_____________________________ _____________________________

Hope S. Freiwald Aline Fairweather

_____________________________ _____________________________

Erin Brennan Kirstin J. Miller

DECHERT PRICE & RHOADS

4000 Bell Atlantic Tower

1717 Arch Street

Philadelphia, PA 19103-2793

(215) 994-4000

Case 2:02-cv-04137-JG Document 7 Filed 09/11/2002 Page 1 of 1
Before the Second Division,

January 18, 1950

No. 53929.

#### American Express Co. et al. *v.*United States,

protests 138835-K, etc. (New York).

Opinion hy

Ford, J.

Following the authorities cited in Abstract 15400 the court dismissed the protests.
H. Res. 631 

In the House of Representatives, U. S., 

November 29, 2017. 

Resolved, That upon adoption of this resolution it shall 

be in order to consider in the House the bill (H.R. 3017) to 

amend the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 to reauthorize and improve the brownfields program, and for other purposes. All 

points of order against consideration of the bill are waived. 

An amendment in the nature of a substitute consisting of the 

text of Rules Committee Print 115–40 shall be considered as 

adopted. The bill, as amended, shall be considered as read. 

All points of order against provisions in the bill, as amended, 

are waived. The previous question shall be considered as ordered on the bill, as amended, and on any further amendment 

thereto, to final passage without intervening motion except: 

(1) one hour of debate equally divided and controlled by the 

chair and ranking minority member of the Committee on Energy and Commerce; and (2) one motion to recommit with or 

without instructions. 
2 

•HRES 631 EH 

SEC. 2. Upon adoption of this resolution it shall be in 

order to consider in the House the bill (H.R. 3905) to require 

congressional approval of any mineral withdrawal or monument designation involving the National Forest System lands 

in the State of Minnesota, to provide for the renewal of certain mineral leases in such lands, and for other purposes. All 

points of order against consideration of the bill are waived. 

An amendment in the nature of a substitute consisting of the 

text of Rules Committee Print 115–41 shall be considered as 

adopted. The bill, as amended, shall be considered as read. 

All points of order against provisions in the bill, as amended, 

are waived. The previous question shall be considered as ordered on the bill, as amended, and on any further amendment 

thereto, to final passage without intervening motion except: 

(1) one hour of debate equally divided and controlled by the 

chair and ranking minority member of the Committee on 

Natural Resources; (2) the further amendment printed in the 

report of the Committee on Rules accompanying this resolution, if offered by the Member designated in the report, which 

shall be in order without intervention of any point of order, 

shall be considered as read, shall be separately debatable for 

the time specified in the report equally divided and controlled 

by the proponent and an opponent, and shall not be subject 
3 

•HRES 631 EH 

to a demand for a division of the question; and (3) one motion to recommit with or without instructions. 

Attest: 

Clerk.
Exhibit 32(i)

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the quarterly report on Form 10-QSB of Dialog Group,
Inc. (the "Company") for the quarter ended June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, Peter V. DeCrescenzo, the Chief Executive Officer of the Company,
hereby certifies, pursuant to 18 U.S.C. section 1350, that:

     (1) the Report fully complies with the requirements of Section 13(a)
or15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: August 13, 2004

                                               /s/ Peter V. DeCrescenzo
                                             -----------------------------
                                               Peter V. DeCrescenzo, CEO
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Shoe Pavilion, Inc. (the "Company") on Form 10-Q for the period ended
March 29, 2008 (the "Report"), I, Michael P. McHugh, Executive Vice President and Chief Financial Officer of the Company certify, pursuant to
18 U.S.C.  §1350, as adopted pursuant to  §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

/s/ MICHAEL P. MCHUGH Executive Vice President and Chief Financial Officer
                   May 12, 2008

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and
is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange
Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language
contained in such filing.

---
Exhibit 32.2       CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report on Form 10-Q of Par Pharmaceutical Companies, Inc. (the Company) for the quarterly period ended June 27, 2009, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Lawrence A. Kenyon, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:  (1) The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.  This certification accompanies the Report and shall not be deemed filed with the Securities and Exchange Commission and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933 or Securities Exchange Act of 1934 (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.  /s/ Lawrence A. KenyonLawrence A. Kenyon
Executive Vice President and Chief Financial Officer August 4, 2009
(Reap. Dec. 10282)

Entry No. 6847.

#### Frank P. Dow Co., Inc. *v.*United States

(Decided June 27, 1962)

*Lawrence & Tuttle*for the plaintiff.

*Joseph D. Guilfoyle,*Acting Assistant Attorney General, for the defendant.

*341OlxveR, Chief Judge:

Counsel for the parties have submitted tire above-enumerated appeal for reappraisement for decision upon stipulation, reading as follows:

> 1. That the merchandise an’d the issues involved in the appeals for reappraisement enumerated in Schedule “A” hereto attached and made a part hereof are the same in all material respects as those involved in *United States*v. *Gitkin Co.,*A.R.D. 132, and that the record in the cited case may be incorporated in the record herein.

> 2. That the involved merchandise was entered or withdrawn from warehouse for consumption on or after February 27, 1958 and is not identified in the Final List published by the Secretary of the Treasury pursuant to the Customs Simplification Act of 1956 (T.D. 54521).

> 3. At the time of exportation of the merchandise involved herein, the prices at which such or similar merchandise was freely sold for exportation to the United States to all purchasers in the principal markets of the country of exportation, in the usual wholesale quantities and in the ordinary course of trade, including the cost of all containers and coverings of whatever nature and all other costs, charges and expenses incidental to placing the merchandise in condition packed ready for shipment to the United States, were the appraised values, less the amounts marked “X” in red ink by the Examiner.

> 4. That the above-entitled appeal for reappraisement may be submitted on this stipulation, the same being limited to the merchandise and the issues described hereinabove and abandoned in all other respects.

On the agreed facts, I find export value, as defined in section 402 (b), Tariff Act of 1930, as amended by the Customs Simplification Act of 1956, to be the proper basis for the determination of the values of the merchandise involved and that such values are the appraised values, less the amounts marked “X” in red ink by the examiner.

Judgment will issue accordingly.
한 통의 전화로 

부동산압류를 

방지할 수 있습니다
현재 담보대출 상환에 어려움을 

겪고 있거나 앞으로 문제가 있을 것으로 

예상된다면 당사가 도와드릴 수 있습니다. 연방 

담보대출 조정 프로그램에 따른 조정을 포함하여 

귀하의 집을 지키는 데 도움이 될 수 있는 

부동산압류 방지 대책에 대해 논의하려면 당사로 

연락해 주세요. 또는 주택을 지키는 것이 최선의 

방법이 아니라면, 부동산압류 대신 다른 대안을 통해 

집을 포기하면서 더 많은 재정적 안정을 얻는 방법을 

찾아볼 수도 있습니다. 

여기에 로고와 연락처 정보를 넣으세요. 

회사 이름 

1234 도로 이름 

도시 이름, 주 12345
## I N T H E C O U R T O F C R I M I N A L A P P E A L S O F T E X A S NO. WR-94,273-01

EX P ARTE ANTHONY LEXINGTON K OP YCINSKI, Appl icant

ON AP P LICATION FOR A WRIT OF HABEAS CORP US CAUSE NO. 85949-CR- A IN THE 149TH DISTRICT COURT

F ROM BRAZ ORIA COUNTY

Per curiam . O P I N I O N Applicant was convicted of murder and sentenc ed to life y ear s’ imprisonment. The Thirteenth Court of Ap p ea l s af fi rmed his conviction. Kopycinski v. State , No. 13-20-00548- CR (Tex. App.—Corpus Christi-Edinburgh, May 26, 2022) (not desig nated for publication). Applicant filed t his application for a writ of habeas corpus in the county of conviction, and the dis t ri ct clerk forwa rded it to this Court. See T E X . C O D E C R I M . P R O C . art. 11.07. Applicant essentially contends that he did not rec eive appellate counsel’s notice of the court of appea ls’s judgme nt and adviseme nt of the rig ht to file a pro se petition f or discretionar

y revie w unt i l af t er t h e d eadline for filing such a petition had passed. The State and the trial court both

rec ommend that Applicant be allowed to file an out-of-time pro se petition for discretionar y revie w.2

Acc ording to the rec ord, appellate counsel timely sent a letter to Applicant advising him of the court of appea ls’s ruling and his rig ht to file a pro se petition for discretionar y revie w; howeve r, the letter was returned to appellate counsel as undelivera ble because Applicant had been removed from the address of hi s last known prison unit. By the t ime Applicant rece ived appellate counse l ’s s ec o n d letter, the deadline for filing, as well as the deadline for reque sting an extension to file, a petition for discretionar

y revie w had both passe d. Relief is g rante d. Applicant may file an out-of-time petition for discretionar y revie w of the judgme nt of the Thirteenth Court of Appea ls in cause number 13-20-00548- CR. Should Applicant decide to file a petition for discretionar y revie w, he must file it wit h t h i s C o u rt within thirty day s from the da te of this Court’s mandate. Copies of this opinion shall be sent to the Texas Depa rtment o f Cr im in a l Ju s ti c e

– Co r rec tional I nstitut ions Division and the Boa rd of Par dons and Paroles.

Deliver ed: Novembe r 16, 2022 Do not publish
Michigan Supreme Court

Lansing, Michigan

Robert P. Young, Jr., Chief Justice

Stephen J. Markman

Brian K. Zahra

Bridget M. McCormack

David F. Viviano

Richard H. Bernstein

Joan L. Larsen, Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

June 10, 2016

Order 

June 10, 2016

153566(36)

JOANNE JOHNSON, Individually and as Next 

Friend of SAMANTHA JOHNSON, a minor,

Plaintiffs-Appellees,

v

OUTBACK LODGE & EQUESTRIAN CENTER, 

LLC, and OUTBACK LODGE, LLC,

Defendants,

and

GIRL SCOUTS OF NORTHERN INDIANAMICHIANA, INC.,

Defendant-Appellant.

SC: 153566

COA: 323556

Mecosta CC: 12-020925-NO

________________________________________/

On order of the Chief Justice, the motion of defendant-appellant to extend the time 

for filing its reply is GRANTED. The reply will be accepted as timely filed if submitted 

on or before June 17, 2016.
[Federal Register Volume 88, Number 215 (Wednesday, November 8, 2023)]
[Notices]
[Page 77101]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24708]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Research Education Program 
(R25 Clinical Trial Not Allowed).
    Date: December 1, 2023.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G33, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Poonam Pegu, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G33, Rockville, MD 
20852, 240-292-0719, <a href="/cdn-cgi/l/email-protection#81f1eeeeefe0ecaff1e4e6f4c1efe8e9afe6eef7"><span class="__cf_email__" data-cfemail="3949565657585417495c5e4c79575051175e564f">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 3, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-24708 Filed 11-7-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>